Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trialArta M. Monjazeb, Karen Kelly, Alexander A. Merleev et al.|Nature Communications|2023Cited by 21
Atezolizumab plus stereotactic ablative therapy for medically inoperable patients with early-stage non-small cell lung cancer.Karen Kelly, Arta M. Monjazeb, Megan E. Daly et al.|Journal of Clinical Oncology|2020Cited by 12